Clinical Trial Update: Crisaborole Ointment for Skin Toxicity Induced by Cetuximab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Crisaborole ointment to manage skin toxicity associated with cetuximab in metastatic colorectal cancer; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Skin Toxicity

Drugs mentioned

• Cetuximab (cetuximab)
• Crisaborole ointment (crisaborole)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer, Cetuximab | Phase 2 | Status: UNKNOWN